Vanguard Group Inc Sc Pharmaceuticals Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,708,946 shares of SCPH stock, worth $5.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,708,946

Previous 1,386,196 23.28%

Holding current value

$5.47 Million

Previous $6.03 Million 29.24%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.12 - $5.51 $1.33 Million - $1.78 Million	322,750 Added 23.28%	1,708,946 $7.79 Million
Q2 2024 Aug 13, 2024	BUY	$3.51 - $5.21 $57,423 - $85,235	16,360 Added 1.19%	1,386,196 $6.03 Million
Q1 2024 May 10, 2024	SELL	$4.86 - $6.39 $252 - $332	-52 Reduced -0.0%	1,369,836 $6.88 Million
Q4 2023 Feb 14, 2024	BUY	$4.7 - $6.63 $709,093 - $1 Million	150,871 Added 12.38%	1,369,888 $8.59 Million
Q3 2023 Nov 14, 2023	BUY	$7.0 - $9.82 $182,077 - $255,428	26,011 Added 2.18%	1,219,017 $8.68 Million
Q2 2023 Aug 14, 2023	BUY	$8.94 - $11.74 $1.73 Million - $2.27 Million	193,039 Added 19.3%	1,193,006 $12.2 Million
Q1 2023 May 15, 2023	BUY	$5.59 - $9.47 $687,340 - $1.16 Million	122,959 Added 14.02%	999,967 $9.07 Million
Q4 2022 Feb 10, 2023	BUY	$4.02 - $7.53 $1.05 Million - $1.96 Million	260,450 Added 42.24%	877,008 $6.29 Million
Q4 2021 Feb 14, 2022	SELL	$3.88 - $6.9 $1,901 - $3,381	-490 Reduced 0.08%	616,558 $3.1 Million
Q3 2021 Nov 12, 2021	BUY	$4.93 - $7.15 $39,933 - $57,915	8,100 Added 1.33%	617,048 $4.1 Million
Q2 2021 Aug 13, 2021	BUY	$5.19 - $7.38 $3.16 Million - $4.49 Million	608,948 New	608,948 $3.72 Million

Others Institutions Holding SCPH

# of Institutions

Shares Held

37.1M

Call Options Held

110K

Put Options Held

12.1K

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $87.7M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Sc Pharmaceuticals Inc. Transaction History